Marc Scheineson comments on new opioid legislation requiring the U.S. Food and Drug Administration to write guidance on drug abuse potential.
In the News
September 30, 2018
The Pink Sheet | Opioid Approvals: Congress Wants US FDA Guidance on Abuse Potential
Media Contact